Menu

• Ask a Health Expert about POOR VENOUS ACCESS
• Post Your Side Effect related to POOR VENOUS ACCESS
• POOR VENOUS ACCESS and FDA Warnings
• POOR VENOUS ACCESS in Patients Wiki
• Report POOR VENOUS ACCESS in Drug Side Effect Survey

POOR VENOUS ACCESS side effect

What is POOR VENOUS ACCESS ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Rebif Side Effects Report #5339965-2
Consumer or non-health professional from UNITED STATES reported REBIF problem on May 16, 2007. Female patient, 59 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: poor venous access, sarcoidosis, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.

Natalizumab Side Effects Report #5535049-9
NATALIZUMAB problem was reported by a Health Professional from UNITED STATES on Nov 20, 2007. Female patient was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, poor venous access, urinary tract infection, . NATALIZUMAB dosage: 300 MG;QM;IV. Patient was hospitalized. Patient recovered.

Natalizumab Side Effects Report #5513306-X
Health Professional from UNITED STATES reported NATALIZUMAB problem on Oct 30, 2007. Female patient was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, poor venous access, urinary tract infection, . NATALIZUMAB dosage: 300 MG;QM; IV. Patient was hospitalized. Patient recovered.

Avonex Side Effects Report #5484251-3
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 26, 2007. Female patient, 55 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: catheter thrombosis, poor venous access, urinary tract infection, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.


Refacto Side Effects Report #5333553-X
Physician from AUSTRIA reported REFACTO problem on May 15, 2007. Female patient, weighting 52.91 lb, was treated with REFACTO. After drug was administered, patient experienced the following problems/side effects: factor viii inhibition, poor venous access, . REFACTO dosage: unknown. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5477787-2
FABRAZYME problem was reported by a Physician from FRANCE on Sept 17, 2007. Male patient, 55 years of age, weighting 149.9 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: brain stem ischaemia, extravasation, poor venous access, . FABRAZYME dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with CELLCEPT, NEORAL, UNALFA, VASTIN, ZYLORIC, FONZYLANE, ALDACTONE. Patient died on 05/26/2007.

Chantix Side Effects Report #5471782-5
Consumer or non-health professional from UNITED STATES reported CHANTIX problem on Sept 17, 2007. Female patient, weighting 119.2 lb, was diagnosed with osteoporosis and was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: abnormal dreams, cataract operation, poor venous access, vessel puncture site haematoma, . CHANTIX dosage: unknown. During the same period patient was treated with ACTONEL, SYNTHROID, GLUCOSAMINE, CALCIUM, VITAMINS, HYDROCODONE BITARTRATE, TRAZODONE. Patient recovered.

Zelnorm Side Effects Report #5399894-5
ZELNORM problem was reported by a Consumer or non-health professional from UNITED STATES on July 23, 2007. Female patient, 54 years of age, was diagnosed with constipation and was treated with ZELNORM. After drug was administered, patient experienced the following problems/side effects: catheterisation venous, cerebrovascular accident, poor venous access, . ZELNORM dosage: unknown. Patient recovered.

Zelnorm Side Effects Report #5399894-5
Consumer or non-health professional from UNITED STATES reported ZELNORM problem on July 23, 2007. Female patient, 54 years of age, was diagnosed with constipation and was treated with ZELNORM. After drug was administered, patient experienced the following problems/side effects: catheterisation venous, cerebrovascular accident, poor venous access, . ZELNORM dosage: unknown. Patient recovered.


Fabrazyme Side Effects Report #5788447-2
FABRAZYME problem was reported by a Health Professional from UNITED STATES on June 12, 2008. Male patient, 39 years of age, weighting 176.4 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: clostridium difficile colitis, hypovolaemia, poor venous access, renal failure acute, . FABRAZYME dosage: 80 MG, Q2W, INTRAVENOUS; 70 MG, Q2W, INTRAVENOUS; 1 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Idursulfase Side Effects Report #5331731-7
Physician from ITALY reported IDURSULFASE problem on Apr 19, 2007. Male patient, 19 years of age, weighting 115.7 lb, was diagnosed with mucopolysaccharidosis ii and was treated with IDURSULFASE. After drug was administered, patient experienced the following problems/side effects: bacteraemia, infusion related reaction, poor venous access, pyrexia, staphylococcal infection, . IDURSULFASE dosage: unknown. Patient was hospitalized. Patient recovered.